Freeline Evaluating Options After No Home Run For Hem B Gene Therapy

At Crossroads As Rivals Advance

 
• By Andrew McConaghie
  
Factor IX
All three patients saw their Factor IX levels rise to normal levels - but these fell back in two patients after the trial cut-off period. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapy Areas